Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $549.52 | 11 | 77.4% |
| Education | $160.79 | 2 | 22.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $285.79 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $129.54 | 2 | $0 (2023) |
| Horizon Pharma plc | $128.18 | 1 | $0 (2018) |
| GENZYME CORPORATION | $120.17 | 4 | $0 (2023) |
| Optinose US, Inc. | $19.99 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $15.56 | 1 | $0 (2017) |
| PFIZER INC. | $11.08 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86.12 | 2 | Regeneron Healthcare Solutions, Inc. ($66.13) |
| 2023 | $195.08 | 5 | Regeneron Healthcare Solutions, Inc. ($94.66) |
| 2022 | $164.96 | 2 | Regeneron Healthcare Solutions, Inc. ($125.00) |
| 2018 | $248.59 | 3 | Horizon Pharma plc ($128.18) |
| 2017 | $15.56 | 1 | AstraZeneca Pharmaceuticals LP ($15.56) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $66.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/06/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/21/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $94.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Immunology | ||||||
| 09/14/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: Immunology | ||||||
| 04/18/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: VACCINES | ||||||
| 03/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Immunology | ||||||
| 11/29/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $39.96 | General |
| Category: Immunology | ||||||
| 03/17/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/30/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $109.33 | General |
| Category: VACCINES | ||||||
| 05/21/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: DERMATOLOGY | ||||||
| 04/19/2018 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | Cash or cash equivalent | $128.18 | General |
| Category: RAYOS | ||||||
| 02/07/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 22 | 380 | $8,830 | $5,298 |
| 2020 | 2 | 24 | 223 | $5,120 | $2,708 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 11 | 257 | $5,140 | $3,920 | 76.3% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 11 | 123 | $3,690 | $1,378 | 37.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 12 | 157 | $3,140 | $2,061 | 65.6% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 12 | 66 | $1,980 | $646.98 | 32.7% |
About Dr. Jayasri Indaram, MD
Dr. Jayasri Indaram, MD is a Allergy & Immunology healthcare provider based in Ozone Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255331302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jayasri Indaram, MD has received a total of $710.31 in payments from pharmaceutical and medical device companies, with $86.12 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($549.52).
As a Medicare-enrolled provider, Indaram has provided services to 46 Medicare beneficiaries, totaling 603 services with total Medicare billing of $8,006. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Ozone Park, NY
- Active Since 07/29/2005
- Last Updated 12/05/2013
- Taxonomy Code 207K00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255331302
Products in Payments
- DUPIXENT (Biological) $405.96
- SHINGRIX (Biological) $129.54
- RAYOS (Drug) $128.18
- Xhance (Drug) $19.99
- BEVESPI AEROSPHERE (Drug) $15.56
- EUCRISA (Drug) $11.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.